Abstract
A replicative analysis of associations of 15 SNPs located in the regions of 11 genes (TCF4, VRK2, NOTCH4, ZNF804A, AGBL1, RELN, ZFP64P1, KCNB2, CSMD1, CPVL, NRIP1) and three intergenic regions (SLCO6A1/LINCOO491, LOC105376248/LOC105376249, SPA17/NRGN) with schizophrenia was conducted in the Russian population of the Siberian region. These SNPs were previously identified in genome-wide association studies (GWAS) of schizophrenia and cognitive abnormalities. The present study confirmed associations of KCNB2 rs2247572, CSMD1 rs2616984, and intergenic rs12807809 located in SPA17/NRGN with schizophrenia. It was established that the frequency of the CSMD1 rs2616984 G/G genotype was higher in patients compared to the control group (OR = 1.73; CI: 1.14–2.62; р = 0.0337). The frequencies of the KCNB2 rs2247572 TT genotype (OR = 0.41; CI: 0.20–0.87; р = 0.0485) and intergenic rs12807809 CT genotype located in SPA17/NRGN (OR = 0.70; CI: 0.53–0.94; р = 0.0464) were significantly decreased in patients compared to the control group.
Similar content being viewed by others
References
http://www.ncbi.nlm.nih.gov/pubmed.
Mosolov, S.N., Some current theoretical problems of diagnostics, classification, neurobiology and treatment of schizophrenia: a comparison of foreign and domestic approaches, Korsakov J. Neurol. Psychiatry, 2010, vol. 6, pp. 4–11.
The World Health Report 2001—Mental Health: New Understanding, New Hope. http://www.who.int/whr/2001/en/.
Stefansson, H., Ophof, R.A., Steinberg, S., et al., Common variants conferring risk of schizophrenia, Nature, 2009, vol. 460, no. 7256, pp. 744–747.
McCarthy, S.M., McCombie, W.R., and Corvin, A., Unlocking the treasure trove: from genes to schizophrenia biology, Schizophr. Bull., 2014, vol. 40, no. 3, pp. 492–496.
http://www.ebi.ac.uk/gwas.
Golimbet, V.E., Korovaitseva, G.I., Brusov, O.S., et al., The functional state of the serotonergic system and the 5-HTTLPR polymorphism of the serotonin transporter gene in patients with schizophrenia, Mol. Biol. (Moscow), 2010, vol. 44, no. 2, pp. 223–227.
Gareeva, A.E., Traks, T., Koks, S., and Khusnutdinova, E.K., The role of neurotrophins and neurexins genes in the risk of paranoid schizophrenia in Russians and Tatars, Russ. J. Genet., 2015, vol. 51, no. 7, pp. 683–694.
Alfimova, M.V., Abramova, L.I., Aksenova, E.V., et al., Association between polymorphism of the neuregulin gene (NRG1) and cognitive functions in schizophrenia patients and healthy subjects, Korsakov J. Neurol. Psychiatry, 2011, no. 6, pp. 53–57.
Fedorenko, O.Yu., Rudikov, E.V., Gavrilova, V.A., et al., Association of (N251S)-PIP5K2A with schizophrenic disorders: a study of the Russian population of Siberia, Korsakov J. Neurol. Psychiatry, 2013, vol. 113, no. 5, pp. 58–61.
Stepanov, V.A., Bocharova, A.V., Saduakasova, K.Z., et al., Replicative study of susceptibility to childhoodonset schizophrenia in Kazakhs, Russ. J. Genet., 2015, vol. 51, no. 2, pp. 185–192.
Purcell, S.M., Wray, N.R., Stone, J.L., et al., Common polygenic variation contributes to risk of schizophrenia and bipolar disorder, Nature, 2009, vol. 460, no. 7256, pp. 748–752.
Shifman, S., Johannesson, M., Bronstein, M., et al., Genome-wide association identifies a common variant in the reelin gene that increases the risk of schizophrenia only in women, PLoS Genet., 2008, vol. 4, no. 2. e28
Cirulli, E.T., Kasperaviciute, D., Attix, D.K., et al., Common genetic variation and performance on standardized cognitive tests, Eur. J. Hum. Genet., 2010, vol. 18, no. 7, pp. 815–820.
Need, A.C., Attix, D.K., McEvoy, J.M., et al., A genome-wide study of common SNPs and CNVs in cognitive performance in the CANTAB, Hum. Mol. Genet., 2009, vol. 18, no. 23, pp. 4650–4661.
O’Donovan, M.C., Craddock, N., Norton, N., et al., Identification of loci associated with schizophrenia by genome-wide association and follow-up, Nat. Genet., 2008, vol. 40, no. 9, pp. 1053–1055.
Sullivan, P.F., Lin, D., Tzeng, J.Y., et al., Genomewide association for schizophrenia in the CATIE study: results of stage 1, Mol. Psychiatry, 2008, vol. 13, no. 6, pp. 570–584.
Weir, B.S., Genetic Data Analysis: Method for Discrete Population Genetic Data, Sunderland: Sinauer Associates, 1990.
Luykx, J.J., Bakker, S.C., Lentjes, E., et al., Genomewide association study of monoamine metabolite levels in human cerebrospinal fluid, Mol. Psychiatry, 2014, vol. 19, no. 2, pp. 228–234.
Sherva, R., Tripodis, Y., Bennett, D.A., et al., Genome-wide association study of the rate of cognitive decline in Alzheimer’s disease, AlzheimersDement., 2014, vol. 10, pp. 45–52.
Xu, W., Cohen-Woods, S., Chen, Q., et al., Genomewide association study of bipolar disorder in Canadian and UK populations corroborates disease loci including SYNE1 and CSMD1, BMC Med. Genet., 2014, vol. 15, no. 2. doi 10.1186/1471-2350-15-2
Rose, E.J., Morris, D.W., Hargreaves, A., et al., Neural effects of the CSMD1 genome-wide associated schizophrenia risk variant rs10503253, Am. J. Med. Genet._Part B, 2013, vol. 162, no. 6, pp. 530–537.
Koiliari, E., Roussos, P., Pasparakis, E., et al., The CSMD1 genome-wide associated schizophrenia risk variant rs10503253 affects general cognitive ability and executive function in healthy males, Schizophr. Res., 2014, vol. 154, nos. 1–3, pp. 42–47. doi 10.1016/j.schres.2014.02.017
Steen, V.M., Nepal, C., Ersland, K.M., et al., Neuropsychological deficits in mice depleted of the schizophrenia susceptibility gene CSMD1, PLoS One, 2013, vol. 8, no. 11. e79501. doi 10.1371/journal.pone. 0079501
Håvik, B., Le Hellard, S., Rietschel, M., et al., The complement control-related genes CSMD1 and CSMD2 associate to schizophrenia, Biol. Psychiatry, 2011, vol. 70, no. 1, pp. 35–42. doi 10.1016/j.biopsych. 2011.01.030
Shcherbakova, I.V., Activation of innate immunity in schizophrenia, Korsakov J. Neurol. Psychiatry, 2006, vol. 10, pp. 79–82.
Kraus, D.M., Elliott, G.S., Chute, H., et al., CSMD1 is a novel multiple domain complement-regulatory protein highly expressed in the central nervous system and epithelial tissues, J. Immunol., 2006, vol. 176, pp. 4419–4430.
Gendrel, M., Rapti, G., Richmond, J.E., et al., A secreted complement control-related protein ensures acetylcholine receptor clustering, Nature, 2009, vol. 461, pp. 992–996. doi 10.1038/nature08430
Stepanov, V.A., Bocharova, A.V., Marusin, A.V., et al., Replicative association analysis of genetic markers of cognitive traits with Alzheimer’s disease in the Russian population, Mol. Biol. (Moscow), 2014, vol. 44, no. 6, pp. 835–844. doi 10.7868/S0026898414060160
Borghans, J.A., Beltman, J.B., and De Boer, R.J., Mhc polymorphism under host—pathogen coevolution, Immunogenetics, 2004, vol. 55, pp. 732–739.
Hancock, D.B., Romieu, I., Shi, M., et al., Genome-Wide association study implicates chromosome 9q21.31 as a susceptibility locus for asthma in Mexican children, PLoS Genet., 2009, vol. 5, no. 8. e1000623. doi 10.1371/journal.pgen.1000623
Rose, E.J., Morris, D.W., Fahey, C., et al., The effect of the neurogranin schizophrenia risk variant rs12807809 on brain structure and function, Twin Res. Hum. Genet., 2012, vol. 15, no. 3, pp. 296–303. doi 10.1017/thg.2012.7
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © A.V. Bocharova, V.A. Stepanov, A.V. Marusin, V.N. Kharkov, K.V. Vagaitseva, O.Yu. Fedorenko, N.A. Bokhan, A.V. Semke, S.A. Ivanova, 2017, published in Genetika, 2017, Vol. 53, No. 1, pp. 100–108.
Rights and permissions
About this article
Cite this article
Bocharova, A.V., Stepanov, V.A., Marusin, A.V. et al. Association study of genetic markers of schizophrenia and its cognitive endophenotypes. Russ J Genet 53, 139–146 (2017). https://doi.org/10.1134/S1022795417010033
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1022795417010033